NewsBenzingaCompass Therapeutics 第三季度每股收益（EPS）为（0.15），低于预期的（0.13） Compass Therapeutics 第三季度每股收益（EPS）为（0.15），低于预期的（0.13） Benzinga 2026.11.09 13:10 (GMT+0) Open on Benzinga Other news Strategy Buys $82M in Bitcoin, Buys Back $188M of STRC Truist Securities Maintains Hold on AdvanSix, Lowers Price Target to $16 Truist Securities Maintains Hold on APA, Raises Price Target to $50 Truist Securities Maintains Buy on AMN Healthcare Services, Raises Price Target to $45 US Government to Brief Congress on Matters Related to Nvidia CEO Jensen Huang Heron Therapeutics Q3 EPS $(0.03), Inline, Sales $35.250M Miss $37.500M Estimate
